Nanosonics Limited (OTCMKTS:NNCSF) Short Interest Down 50.3% in August

Nanosonics Limited (OTCMKTS:NNCSF) was the target of a significant drop in short interest during the month of August. As of August 31st, there was short interest totaling 126,777 shares, a drop of 50.3% from the August 15th total of 254,902 shares. Based on an average daily trading volume, of 3,840 shares, the short-interest ratio is currently 33.0 days.

Analysts Set New Price Targets

Separately, Royal Bank Of Canada raised shares of Nanosonics from a “sector perform” rating to an “outperform” rating in a report on Tuesday. One research analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the company currently has a consensus rating of “Buy”.

Nanosonics Stock Performance

Shares of OTCMKTS NNCSF remained flat at $2.02 during trading on Wednesday. The company’s stock had a trading volume of 20,000 shares, compared to its average volume of 2,589. The company has a 50-day moving average price of $2.19 and a two-hundred day moving average price of $2.35. Nanosonics has a twelve month low of $1.93 and a twelve month high of $3.06.

About Nanosonics

Nanosonics Limited is an Australia‐based medical technology company specializing in infection prevention solutions for the healthcare sector. Founded in 2001 and headquartered in Sydney, the company is best known for developing and commercializing its proprietary Trophon platform, which provides automated high‐level disinfection of ultrasound probes using sonically activated hydrogen peroxide vapor. Nanosonics holds numerous patents and regulatory approvals across multiple jurisdictions, positioning it as a leader in point‐of‐care decontamination.

The company’s flagship product, Trophon EPR, is designed to address the critical need for rapid, reliable disinfection of endocavity and surface ultrasound transducers.